Clinical progression of HIV infection Solehah Jeffrey 0610108
Outline 1. 2. 3. 4.
5. 6.
Overview Primary infection/ seroconversion Clinical latency/intermediate stage Acquired immunodeficiency syndrome (AIDS) Summary References
Overview
Overview
Start with CD4 of 1000cells/ml blood
In HIV infected persons, the CD4 count declines by about 10cells/ml blood/year initially
However, towards the end, the CD4 count declines by 30-60cells/ml blood/year
How does HIV infection progresses? Primary infection/seroconversi on Clinical latency/intermediate stage AIDS
Primary infection/ seroconversion
The incubation periods is 2-4 weeks. Silent both clinically and serologically
Symptomatic in 70 %-80% of cases
Occurs 6-8 weeks after exposure
Primary infection/ seroconversion
Symptoms include
Fever Arthralgia/ Myalgia Headache Photophobia Lethargy Sore throat with cervical lymphadenopathy Mucosal ulcers Occasionally –a transient faint pink maculopapular rash.
Rash of acute HIV infection
Primary infection/ seroconversion Symptomatic recovery occurs after 1-3 weeks
and recovery is usually complete Parallel to return of CD4 count and fall in the viral load
How does HIV infection progresses? Primary infection/seroconversion
Clinical latency/intermediate stage AIDS
Clinical latency/ intermediate stage
Early Immune deficiency (CD4>500) and
Intermediate Immune Deficiency (CD4 200-500)
Early Immune deficiency Prolonged asymptomatic period (8-10 years) (CD4>500)
Active viral replication takes place within lymphoid tissue
Sustained viraemia with decline in CD4 count
Generally good immune response
Serocon Early version (CD4>500)
CD4 CELL COUNT
PGL Polymyositis Recurrent vaginal candidiasis
500
200
100 50
Intermediate CD4 <500>200
Advanced CD4<200
Early Immune deficiency Persistent generalized lymphadenopathy (CD4>500) (PGL)
Lymphadenopathy(<1cm) at two or more extrainguinal sites for more than 3 months in the absence of causes other than HIV infection. Usually symmetical, firm, mobile and non-tender. May disappear with disease progression
Intermediate Immune Deficiency (CD4 200-500)
Signs and symptoms of immunocompromised
Risk of opportunistic infection and malignancy
Develop constitutional symptoms such as fever, weight loss, and night sweats
Skin and mucosal surfaces are first affected
Serocon Early version (CD4>500)
Intermediate CD4 <500>200
CD4 CELL COUNT
Acute primary infection PGL Polymyositis Recurrent vaginal candidiasis
500
200
100 50
Pulmonary tuberculosis Herpes zoster Oropharyngeal candidiasis Oral hairy leukoplakia Salmonellosis Kaposi’s sarcoma HIV associated ITP Cervival intraepithelial neoplasia II-III Lymphoid interstitial pneumonitis(LIP)
Advanced CD4<200
How does HIV infection progresses? Primary infection/seroconversion Clinical latency/intermediate stage
AIDS
Acquired Immunodeficiency Syndromes(AIDS)
Diagnosis:
Having a CD4 count of less than 200 Serologic evidence of HIV infection One of the AIDS-defining opportunistic infections
Develops for a median of 2 years followed by death
Serocon Early version (CD4>500)
Intermediate CD4 <500>200
Advanced CD4<200
CD4 CELL COUNT
Acute primary infection PGL Polymyositis Recurrent vaginal candidiasis
500
200
100 50
Pulmonary tuberculosis Herpes zoster Oropharyngeal candidiasis Oral hairy leukoplakia Salmonellosis Kaposi’s sarcoma HIV associated ITP Cervival intraepithelial neoplasia II-III Lymphoid interstitial pneumonitis(LIP)
PCP Chronic mucocutaneous herpes simplex Chronic cryptosporidial diarrhoea Microsporidium Oesophageal candidiasis Miliary or extrapulmonary tuberculosis HIV-asociated wasting Peripheral neuropathy Cerebral toxoplasmosis Cryptococcal meningitis Non-Hodgkin Lymphoma MAI CMV
Acquired Immunodeficiency Syndromes(AIDS)
Summary 1000 900 800
CD4 counts
700 600
Primary Infection
CD4
Clinical latency/ Intermediate stage
500 400 300 200 100
AIDS-defining illness
0 Years : mean survival ~ 10 yrs.
References
Clinical Medicine, Kumar & Clark, sixth edtion, 2005, Elsevier Clinical microbiology, Gladwin & Trattler, second edition, 1999
THANK YOU
Symptomatic HIV infection As viral load rises, the CD4 count falls Clinical picture is a result of
Direct HIV effects Immunosuppression
Clinical consequence depends on three factors
1.
2. 3.
The microbial exposure of the patient throughout life The pathogenicity of organisms encountered Degree of immunosuppression of the host
What are the stages of HIV disease?
The Centers for Disease Control (CDC) has a disease classification system based on immune function and clinical status.
Each patient is classified with a number which is reflective of CD4 count, and a letter reflective of clinical status.
This provides clinical and prognostic information of the patients.
CDC Classification of HIV Infection A CD4 Cell Categories Asymptomatic (cells/mm3) OR Acute seroconver sion illness OR PGL
B HIV related conditions (Not A or C)
C AIDS Indicator Condition
> 500
A1
B1
C1
200-499
A2
B2
C2
< 200
A3
B3
C3
CORRELATION BETWEEN CD4 COUNT AND HIV–ASSOCIATED DISEASES >500cells/mm3 Acute primary infection Progressive generalised lymphadeno Pathy(PGL) Recurrent vaginal candidiasis 200-500 cells/mm3 Pulmonary tuberculosis Herpes zoster Oropharyngeal candidiasis Oral hairy leukoplakia Salmonellosis Kaposi’s sarcoma HIV associated ITP Cervival intraepithelial neoplasia II-III Lymphoid interstitial pneumonitis(LIP)
<200cells/mm3 Pneumocystis carinii pneumonia Chronic mucocutaneous herpes simplex Chronic cryptosporidial diarrhoea Microsporidium Oesophageal candidiasis Miliary or extrapulmonary tuberculosis HIV-asociated wasting Peripheral neuropathy <100cells/mm3 Cerebral toxoplasmosis Cryptococcal meningitis Non-Hodgkin’s lymphoma Primary cerebral lymphoma HIV-associated dementia Progressive multifocal leucoencephalopathy <50 cells/mm3 Disseminated Mycobacterium avium intracellulare(MA!) CMV retinitis